Marta Pomares Marco

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Interquim, S.a.. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marta Pomares Marco. Retrieved from https://idiyas.com/inventor/marta-pomares-marco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 2)

% Patents Active = 50.0

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 2.5

ph-index = 1

Company Filing History:

4 out of 22

Interquim, S.a.

patents

Years Active: 2013-2025

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12312315 - Process for the preparation of aripiprazole lauroxil (2025-05-27),

2. 12172979 - Process for the preparation of aripiprazole lauroxil (2024-12-24),

3. 9365544 - Process for the preparation of intermediates for the synthesis of Dabigatran Etexilate, and crystalline forms of said intermediates (2016-06-14),

4. 8604242 - Process for the preparation of optically active (S)-(−)-2-(N-propylamino)-5-methoxytetraline and (S)-(−)-2-(N-propylamino)-5-hydroxytetraline compounds (2013-12-10),

Title: Inventor Marta Pomares Marco: Innovating in Pharmaceutical Chemistry

Introduction

Marta Pomares Marco, based in Sant Cugat del Vallès, ES, is a distinguished inventor recognized for her contributions to pharmaceutical chemistry. With a total of four patents, she has focused her research on innovative processes that enhance the preparation of important pharmaceutical compounds.

Latest Patents

Marta's latest patents involve the development of effective processes for the synthesis of aripiprazole lauroxil. The first patent outlines a method that includes reacting 1-(hydroxymethyl) aripiprazole with lauric anhydride in the presence of DMAP and a solvent. The second patent details a similar process but utilizes lauric acid and a suitable carboxyl activating agent. Additionally, she describes the preparation of 1-(hydroxymethyl) aripiprazole by reacting aripiprazole with paraformaldehyde without the addition of water. These patents enhance the efficiency and effectiveness of pharmaceutical production.

Career Highlights

Marta Pomares Marco is currently employed at Interquim, S.A., where she leverages her expertise to advance pharmacological innovations. Her work at Interquim has contributed significantly to the field, making pharmaceutical processes more efficient and reliable.

Collaborations

Throughout her career, Marta has collaborated with notable colleagues, including Francisco Marquillas Olondriz and Francisco De Asís Marquillas Olondriz. Together, they have worked towards pushing the boundaries of pharmaceutical research and development.

Conclusion

Marta Pomares Marco stands out as an influential inventor in the pharmaceutical sector. Her patents not only reflect her innovative spirit but also contribute significantly to advancements in drug preparation techniques. As she continues her work at Interquim, her contributions will undoubtedly play a pivotal role in the future of pharmaceutical sciences.

Profile summary based on public USPTO records.